A Study of Lerociclib in Participants With Advanced Breast Cancer

NCT05085002 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
100
Enrollment
INDUSTRY
Sponsor class

Stopped The study is being closed based on corporate changes at EQRx and is not related to any efficacy or safety issues with lerociclib.

Conditions

Interventions

Sponsor

EQRx, Inc.